Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 21, 1991 - Issue 3
12
Views
34
CrossRef citations to date
0
Altmetric
Research Article

Contrasting systemic stabilities of the acyl and phenolic glucuronides of diflunisal in the rat

, &
Pages 403-415 | Received 12 Apr 1990, Accepted 10 Aug 1990, Published online: 22 Sep 2008

References

  • Benet L. Z., Spahn H. Acyl migration and covalent binding of drug glucuronides—potential toxicity mediators. Cellular and Molecular Aspects of Glucuronidation, G. Siest, J. Magdalou, B. Burchell. John Libbey Eurotext, London 1988; 261–269
  • Caldwell J., Grubb N., Sinclair K. A., Hutt A. J., Weil A., Fournel-Gigleux S. Structural and stereochemical aspects of acyl glucuronide formation and reactivity. Cellular and Molecular Aspects of Glucuronidation, G. Siest, J. Magdalou, B. Burchell. John Libbey Eurotext, London 1988; 185–192
  • Dickinson R. G., King A. R. Reactivity considerations in the analysis of glucuronide and sulfate conjugates of diflunisal. Therapeutic Drug Monitoring 1989; 11: 712–720
  • Dickinson R. G., Harland R. C., Ilias A. M., Rodgers R. M., Kaufman S. N., Lynn R. K., Gerber N. Disposition of valproic acid in the rat: dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect. Journal of Pharmacology and Experimental Therapeutics 1979; 221: 583–595
  • Dickinson R. G., Hooper W. D., Eadie M. J. pH-Dependent rearrangement of the biosynthetic ester glucuronide of valproic acid to β-glucuronidase-resistant forms. Drug Metabolism and Disposition 1984; 12: 247–252
  • Dickinson R. G., Kluck R. M., Hooper W. D., Patterson M., Chalk J. B., Eadie M. J. Rearrangement of valproate glucuronide in a patient with drug-associated hepatobiliary and renal dysfunction. Epilepsia 1985; 26: 589–593
  • Dickinson R. G., Kluck R. M., Wood B. T., Eadie M. J., Hooper W. D. Impaired biliary elimination of β-glucuronidase-resistant ‘lucuronides’ of valproic acid after intravenous administration in the rat. Evidence for oxidative metabolism of the resistant isomers. Drug Metabolism and Disposition 1986; 14: 255–262
  • Dickinson R. G., King A. R., Verbeeck R. K. Elimination of diflunisal as its acyl glucuronide, phenolic glucuronide and sulfate conjugates in bile-exteriorized and intact rats. Clinical and Experimental Pharmacology and Physiology 1989; 16: 913–924
  • Faed E. M. Decreased clearance of diflunisal in renal insufficiency—an alternative explanation. British Journal of Clinical Pharmacology 1980; 10: 185–186
  • Faed E. M. Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs. Drug Metabolism Reviews 1984; 15: 1213–1249
  • Hansen-Moller J., Dalgaard L., Hansen S. H. Reversed-phase high-performance liquid chromatographic assay for the simultaneous determination of diflunisal and its glucuronides in serum and urine. Rearrangement of the 1-O-acylglucuronide. Journal of Chromatography 1987; 420: 99–109
  • Hansen-Moller J., Cornett C., Dalgaard L., Hansen S. H. Isolation and identification of the rearrangement products of diflunisal 1-O-acyl glucuronide. Journal of Pharmaceutical and Biomedical Analysis 1988; 6: 229–240
  • Hyneck M. L., Munafo A., Benet L. Z. Effect of pH on acyl migration and hydrolysis of tolmetin glucuronide. Drug Metabolism and Disposition 1988; 16: 322–324
  • Levy G. Decreased body clearance of diflunisal in renal insufficiency—an alternative explanation. British Journal of Clinical Pharmacology 1979; 8: 601
  • Lin J. H., Hooke K. F., Yeh K. C., Duggan D. E. Dose-dependent pharmacokinetics of diflunisal in rats: dual effects of protein binding and metabolism. Journal of Pharmacology and Experimental Therapeutics 1985a; 235: 402–406
  • Lin J. H., Yeh K. C., Duggan D. E. Effect of enterohepatic circulation on the pharmacokinetics of diflunisal in rats. Drug Metabolism and Disposition 1985b; 13: 321–326
  • Lin J. H., Ulm E. H., Duggan D. E. Possible mechanisms for reduced plasma clearance of diflunisal in rat experimental renal failure. Journal of Pharmacology and Experimental Therapeutics 1986; 238: 978–984
  • Loewen G. R., Herman R. J., Ross S. G., Verbeeck R. K. Effect of dose on the glucuronidation and sulphation kinetics of diflunisal in man: single dose studies. British Journal of Clinical Pharmacology 1988; 26: 31–39
  • Loewen G. R., McKay G., Verbeeck R. K. Isolation and identification of a new major metabolite of diflunisal in man. The sulfate conjugate. Drug Metabolism and Disposition 1986; 14: 127–131
  • McKinnon G. E., Dickinson R. G. Covalent binding of diflunisal and probenecid to plasma protein in humans: persistence of the adducts in the circulation. Research Communications in Chemical Pathology and Pharmacology 1989; 66: 339–354
  • Meffin P. J., Zilm D. M., Veenendaal J. R. Reduced clofibric acid clearance in renal dysfunction is due to a futile cycle. Journal of Pharmacology and Experimental Therapeutics 1983; 227: 732–738
  • Musson D. G., Lin J. H., Lyon K. A., Tocco D. J., Yeh K. C. Assay methodology for quantification of the ester and ether glucuronide conjugates of diflunisal in human urine. Journal of Chromatography 1985; 337: 363–378
  • Rowe B. J., Meffin P. J. Diisopropylfluorophosphate increases clofibric acid clearance: supporting evidence for a futile cycle. Journal of Pharmacology and Experimental Therapeutics 1984; 230: 237–241
  • Ruelius H. W., Kirkman S. K., Young E. M., Janssen F. W. Reactions of oxaprozin-1-O-acyl glucuronide in solutions of human plasma and albumin. Biological Reactive Intermediates, J. J. Koscis, D. J. Jollow, C. M. Witmer, J. O. Nelson, R. Snyder. Plenum, New York 1986; 431–442
  • Sallustio B. C., Purdie Y. J., Birkett D. J., Meffin P. J. Effect of renal dysfunction on the individual components of the acyl glucuronide futile cycle. Journal of Pharmacology and Experimental Therapeutics 1989; 251: 288–294
  • Sinclair K. A., Caldwell J. The formation of β-glucuronidase resistant glucuronides by the intramolecular rearrangement of glucuronic acid conjugates at mild alkaline pH. Biochemical Pharmacology 1982; 31: 953–957
  • Smith P. C., Hasegawa J., Langendijk P. N. J., Benet L. Z. Stability of acyl glucuronides in blood, plasma and urine: studies with zomepirac. Drug Metabolism and Disposition 1985; 13: 110–112
  • Smith P. C., McDonagh A. F., Benet L. Z. Irreversible binding of zomepirac to plasma protein in vitro and in vivo. Journal of Clinical Investigation 1986; 77: 934–939
  • Tocco D. J., Breault G. O., Zacchei A. G., Steelman S. L., Perrier C. V. Physiological disposition and metabolism of 5-(2′,4′-difluorophenyl)salicyclic acid, a new salicylate. Drug Metabolism and Disposition 1975; 3: 453–466
  • Van Breemen R. B., Fenselau C. Acylation of albumin by 1-O-acyl glucuronides. Drug Metabolism and Disposition 1985; 13: 318–320
  • Verbeeck R. K., Dickinson R. G., Pond S. M. Biliary excretion of diflunisal conjugates in patients with T-tube drainage. European Journal of Clinical Pharmacology 1988; 34: 423–426
  • Verbeeck R. K., Tjandramaga T. B., Mullie A., Verbesselt R., Verperckmoes R., De Schepper P. J. Biotransformation of diflunisal and renal excretion of its glucuronides in renal insufficiency. British Journal of Clinical Pharmacology 1979; 7: 273–282
  • Watt J. A., Dickinson R. G. The effect of diethyl ether, pentobarbitone and urethane anaesthesia on diflunisal conjugation and disposition in rats. Xenobiotica 1990a; 20: 289–301
  • Watt J. A., Dickinson R. G. Reactivity of diflunisal acyl glucuronide in human and rat plasma and albumin solutions. Biochemical Pharmacology 1990b; 39: 1067–1075
  • Watt J. A., Dickinson R. G. Effects of blockage of urine and/or bile flow on diflunisal conjugation and disposition in rats. Xenobiotica 1990c; 20: 835–845
  • Weil A., Guichard J. P., Caldwell J. Interactions between fenofibryl glucuronide and human serum albumin or human plasma. Cellular and Molecular Aspects of Glucuronidation, G. Siest, J. Magdalou, B. Burchell. John Libbey Eurotext, London 1988; 233–236

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.